Max Reinhardt, President, Rest of World at Pacira BioSciences, Inc. (PCRX), sold 56,052 shares at $72.25 ($4.1M) on 2022-04-19, disclosed to the SEC on 2022-04-20.
Open-market sale of $4.1M PCRX by President, Rest of World. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.55 | 8,941 | $658K | 16.0% |
| 2 | $73.55 | 8,941 | $658K | 16.0% |
| 3 | $72.25 | 9,321 | $673K | 16.4% |
| 4 | $72.25 | 9,321 | $673K | 16.4% |
| 5 | $73.99 | 9,764 | $722K | 17.6% |
| 6 | $73.99 | 9,764 |
| $722K |
| 17.6% |
| Total | $73.27 avg | 56,052 | $4.1M | 100% |
| Filing → |
| PCRX | SELL | 2023-06-07 | $83K | — | Filing → |
| PCRX | SELL | 2022-10-11 | $80K | — | Filing → |
| PCRX | SELL | 2022-06-08 | $497K | — | Filing → |